Clinical Trial

A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis

Name: A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis — clinical trial record (NCT07533955)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a Phase 1, first in human study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single ascending doses of JADE201 compared to placebo in participants with Rheumatoid Arthritis

Protocol Amendment History 1 change

critical Recruitment opened 2026-06-02

Trial Details

NCT Number	NCT07533955
Lead Sponsor	Jade Biosciences, Inc.
Conditions	Rhematoid Arthritis
Enrollment	36 participants
Start Date	2026-05-19
Primary Completion	2027-10 (estimated)
Study Completion	2028-10 (estimated)
Updated on ClinicalTrials.gov	2026-06-01